Deans' stroke musings: Stroke rehabilitation treatment: Evaluation of combined application of SGT-700 apparatus and fluoxetine

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, October 4, 2011

Stroke rehabilitation treatment: Evaluation of combined application of SGT-700 apparatus and fluoxetine

I think the apparatus is a weight gym, and fluoxetine is an anti-depressant.
http://ieeexplore.ieee.org/xpl/freeabs_all.jsp?arnumber=6027969

Abstract

A combined therapy of early rehabilitation, SGT-700 apparatus and fluoxetine was used for the treatment of stroke in this study. 206 Cases of patients with stroke were selected based on the diagnostic standard. ADL of patients was evaluated with Barthel index (BI) and the nervous functional deficiency of the patients was evaluated with SSS. There were no significant differences in ADL and SSS scores among group A, B, C and D before the treatment. The scores of patients after the treatment in the different groups were compared with those before the treatment in them and the differences were significant. The comparison in ADL and SSS scores between group B and Group A, and the comparison in ADL and SSS scores between group C and group B were significantly different. The comparison in ADL and SSS scores between group D and group C was significantly different. The results suggests that the combined application of fluoxetine and the therapeutic apparatus can produce a satisfactory curative effect on patients with stroke, and improve the patients' nervous functional deficiency and the ability of daily life.